Theron Pharmaceuticals to Present at the BIO-Europe Spring Conference on March …
Business Wire (press release) Dr. Zhang will provide a company overview and highlight Theron's lead COPD/asthma candidate, TRN-157, for which the company is actively seeking Biopharma partners on a global or regional basis to maximize its broad therapeutic potential in these … |
View full post on asthma – Google News